Abstract
Primary headaches, including migraine and medication overuse headache (MOH), can be conceptualized as biobehavioral disorders based on the interaction of biological, psychological, and environmental factors. This article reviews empirically supported and efficacious behavioral approaches to the treatment and management of headaches in general, with an emphasis on migraine and MOH from a biopsychosocial perspective. Evidence-based behavioral medicine treatments for migraine and MOH are reviewed, including patient education, cognitive behavioral therapy, and biobehavioral training (biofeedback, relaxation training, and stress management). Information regarding psychological comorbidities and risk factors for progression of migraine and the development of MOH is also reviewed. Strategies are provided for enhancing adherence and motivation, as well as facilitating medical communication.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Society of Behavioral Medicine: Definition of behavioral medicine page. Available at http://www.sbm.org/about/definition.asp. Accessed January 2009.
Engel GL: The need for a new medical model: a challenge for biomedicine. Science 1977, 196:129–136.
Andrasik F, Flor H, Turk DC: An expanded view of psychological aspects in head pain: the biopsychosocial model. Neurol Sci 2005, 26:S87–S91.
Saper JR, Hamel RL, Lake AE III: Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005, 25:545–546.
Grazzi L, Andrasik F: Medication-overuse headache: description, treatment, and relapse prevention. Curr Pain Headache Rep 2006, 10:71–77.
Freitag F, Lake AL III, Lipton R, et al.: Inpatient treatment of headache: an evidence-based assessment. Headache 2004, 44:342–360.
Holroyd KA, O’Donnell FJ, Stensland M, et al.: Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001, 285:2208–2215.
Holroyd KA, France JL, Cordingley GE, et al.: Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol 1995, 63:327–330.
Lemstra M, Stewart B, Olszynski W: Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache 2002, 42:845–854.
Harpole L, Samsa G, Jurgelski A, et al.: Headache management program improves outcome for chronic headache. Headache 2003, 43:715–724.
Blumenfeld A, Tischio M: Center of excellence for headache care: group model at Kaiser Permanente. Headache 2003, 43:431–440.
Grazzi L, Andrasik F, D’Amico D, et al.: Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at three years. Headache 2002, 42:483–490.
Rains JC, Lipchik GL, Penzien DB: Behavioral facilitation of medical treatment for headache-part I: review of headache treatment compliance. Headache 2006, 46:1387–1394.
Rains JC, Penzien DB, Lipchik GL: Behavioral facilitation of medical treatment for headache-part II: theoretical models and behavioral strategies for improving adherence. Headache 2006, 46:1395–1403.
Grazzi F, Andrasik F, Usai S, Bussone G: Headache with medication overuse: treatment strategies and proposal of relapse prevention. Neurol Sci 2008, 29:93–98.
Grazzi L, Andrasik F, Usai S, Bussone G: Treatment of chronic migraine with medication overuse: is drug withdrawal crucial? Neurol Sci 2009 (in press).
Cady R, Farmer K, Beach ME, Tarrasch J: Nurse-based education: an office-based comparative model for education of migraine patients. Headache 2008, 48:564–569.
Rothrock JF, Parada VA, Sims C, et al.: The impact of intensive patient education on clinical outcome in a clinicbased migraine population. Headache 2006, 46:726–731.
Lake AE: Medication overuse headache: biobehavioral issues and solutions. Headache 2006, 46(Suppl 3):S88–S97.
Holroyd KA, Cordingley GE, Pingel JD, et al.: Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management training. Headache 1989, 29:148–153.
Lipton RB, Hahn SR, Cady RK, et al.: In-office discussions of migraine: results from the American Migraine Communication Study. J Gen Intern Med 2008, 23:1145–1151.
Hahn SR: Communication in the care of the headache patient. In Wolff’s Headache and Other Head Pain. Edited by Silberstein SD, Lipton RL, Dodick DW. New York: Oxford University Press; 2008:805–824.
Buse DC, Lipton RB: Facilitating communication with patients for improved migraine outcomes. Curr Pain Headache Rep 2008, 12:230–236.
Hahn SR, Lipton RB, Sheftell FD, et al.: Healthcare provider-patient communication and migraine assessment: results of the American Migraine Communications Study (AMCS) Phase II. Curr Med Res Opin 2008, 24:1711–1718.
Holmes WF, MacGregor EA, Sawyer JP, Lipton RB: Information about migraine disability influences physicians’ perceptions of illness severity and treatment needs. Headache 2001, 41:343–350.
Boyle D, Dwinnell B: Invite, listen and summarize: a patient-centered communication technique. Acad Med 2005, 80:29–32.
Andrasik F: What does the evidence show? Efficacy of behavioural treatments for recurrent headaches in adults. Neurol Sci 2007, 28:S70–S77.
Nestoriuc Y, Martin A, Rief W, Andrasik F: Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback 2008, 33:125–140.
Buse DC, Andrasik F: Behavioral medicine for migraine. Neurol Clin 2009, 27:445–465.
Holroyd KA, Andrasik F: A cognitive-behavioral approach to recurrent tension and migraine headache. In Advances in Cognitive-Behavioral Research and Therapy, vol 1. Edited by Kendall PC. New York: Academic Press; 1982:275–320.
McCarran MS, Andrasik F: Migraine and tension headaches. In Anxiety and Stress Disorders: Cognitive-Behavioral Assessment and Treatment. Edited by Michelson L, Ascher M. New York: Guilford Press; 1987:465–483.
Bandura A: Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977, 84:191–215.
French DJ, Holroyd KA, Pinell C, et al.: Perceived self-efficacy and headache-related disability. Headache 2000, 40:647–656.
Heath RL, Saliba M, Mahmassani O, et al.: Locus of control moderates the relationship between headache pain and depression. J Headache Pain 2008, 9:301–308.
Holroyd KA, Drew JB, Cottrell CK, et al.: Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms. Cephalalgia 2007, 27:1156–1165.
Atasoy HT, Atasoy N, Unal AE, et al.: Psychiatric comorbidity in medication overuse headache patients with preexisting headache type of episodic tension-type headache. Eur J Pain 2005, 9:285–291.
Radat F, Creac’h C, Swendsen JD, et al.: Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005, 25:519–522.
Saper JR, Lake AE: Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache 2002, 42:663–674.
Rothrock JF, Conway S, Shuayto M, et al.: Borderline personality disorder and migraine: detection, epidemiology and therapeutic response. Headache 2006, 46:839.
Lake AE III, Saper JR, Hamel RL: Inpatient treatment of intractable headache: outcome for 267 program completers. Headache 2006, 46:893.
Breslau N, Davis GC: Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res 1993, 27:211–221.
Jette N, Patten S, Williams J, et al.: Comorbidity of migraine and psychiatric disorders: a national population-based study. Headache 2008, 48:501–516.
Lanteri-Minet M, Radat F, Chautard HH, et al.: Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain 2005, 118:319–326.
Maizels M, Smitherman TA, Penzien DB: A review of screening tools for psychiatric comorbidity in headache patients. Headache 2006, 46(Suppl 3):S98–S109.
Whooley MA, Avins AL, Miranda J, et al.: Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med 1997, 12:439–445.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington DC: American Psychiatric Press; 2000.
Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606–613.
Spitzer RL, Kroenke K, Williams JB, et al.: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166:1092–1097.
Smitherman TA, Maizels M, Penzien DB: Headache chronification: screening and behavioral management of comorbid depressive and anxiety disorders. Headache 2008, 48:45–50.
Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA: Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache 2006, 46(Suppl 3):S119–S132.
Elder JP, Ayala GX, Harris S: Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med 1999, 17:275–284.
Prochaska JO, Redding A, Evers KE: The transtheoretical model and stages of change. In Health Behavior asnd Health Education. Edited by Glanz K, Lewis FM, Rimer BK. San Francisco: Jossey-Bass; 1997:60–84.
Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change, edn 2. New York: Guildford Press; 2002.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andrasik, F., Buse, D.C. & Grazzi, L. Behavioral medicine for migraine and medication overuse headache. Current Science Inc 13, 241–248 (2009). https://doi.org/10.1007/s11916-009-0041-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-009-0041-x